• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国肺癌患者中p16INK4a基因的高甲基化:生物学及临床意义

Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications.

作者信息

Liu Yong, An Qian, Li Ling, Zhang Dechao, Huang Jinfeng, Feng Xiaoli, Cheng Shujun, Gao Yanning

机构信息

Department of Chemical Etiology and Carcinogenesis, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, P.R.China.

出版信息

Carcinogenesis. 2003 Dec;24(12):1897-901. doi: 10.1093/carcin/bgg169. Epub 2003 Sep 11.

DOI:10.1093/carcin/bgg169
PMID:12970072
Abstract

Promoter hypermethylation of the p16INK4a gene was investigated in 111 cases of tumor tissue, as well as in 136 circulating plasma and 95 sputum samples from Chinese patients with primary lung cancer, using a modified protocol of semi-nested methylation-specific-PCR (MSP). The results showed hypermethylated p16 sequence in 80.2% of tumor tissues and frequencies of 75.7 and 74.7% in plasma and sputum specimens, respectively. Among the patients, 50 cases of matched plasma, sputum and tumor tissue from the same individual were analyzed. Of these, hypermethylation of the p16 promoter was detected in 84.0% of the tumor tissues, with frequencies of 72.0 and 76.0% in the corresponding plasma and sputum, respectively. Notably, only patients whose tumor tissue showed hypermethylation of p16 exhibited the same aberrant methylation in their sputum and/or plasma. Hypermethylation of p16 in sputum and plasma samples may provide a more sensitive approach to molecular diagnosis of lung cancer than relying on conventional cytological analysis. Our data show that a combination of cytological analysis of sputum and examination of p16 hypermethylation in sputum and plasma identified 92.0% (46/50) of the lung cancer patients studied, offering an effective means of early detection of lung cancer.

摘要

采用改良的半巢式甲基化特异性聚合酶链反应(MSP)方案,对111例肿瘤组织以及136份中国原发性肺癌患者的循环血浆样本和95份痰液样本进行p16INK4a基因启动子高甲基化研究。结果显示,80.2%的肿瘤组织中存在p16序列高甲基化,血浆和痰液样本中的频率分别为75.7%和74.7%。在这些患者中,对来自同一患者的50例配对血浆、痰液和肿瘤组织进行了分析。其中,84.0%的肿瘤组织检测到p16启动子高甲基化,相应血浆和痰液中的频率分别为72.0%和76.0%。值得注意的是,只有肿瘤组织显示p16高甲基化的患者,其痰液和/或血浆中才出现相同的异常甲基化。与依靠传统细胞学分析相比,痰液和血浆样本中p16高甲基化可能为肺癌分子诊断提供更敏感的方法。我们的数据表明,痰液细胞学分析与痰液和血浆中p16高甲基化检测相结合,可识别92.0%(46/50)的研究肺癌患者,为肺癌早期检测提供了一种有效手段。

相似文献

1
Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications.中国肺癌患者中p16INK4a基因的高甲基化:生物学及临床意义
Carcinogenesis. 2003 Dec;24(12):1897-901. doi: 10.1093/carcin/bgg169. Epub 2003 Sep 11.
2
[Hypermethylation of p16 gene in clinical specimens of patients with lung cancer].[肺癌患者临床标本中p16基因的高甲基化]
Zhonghua Zhong Liu Za Zhi. 2004 Feb;26(2):75-7.
3
[Detection of hypermethylation of p16 gene in plasma DNA from lung cancer patients].
Zhonghua Zhong Liu Za Zhi. 2004 Mar;26(3):154-7.
4
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.当前和既往吸烟者支气管上皮及痰液中的异常启动子甲基化
Cancer Res. 2002 Apr 15;62(8):2370-7.
5
Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.检测慢性吸烟者痰液及乳腺癌患者原位导管癌中RASSF1A异常启动子高甲基化。
Oncogene. 2003 Jan 9;22(1):147-50. doi: 10.1038/sj.onc.1206057.
6
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.通过荧光甲基化特异性PCR在非小细胞肺癌患者血浆中检测到p16(INK4A)高甲基化。
Clin Cancer Res. 2002 Dec;8(12):3782-7.
7
p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.非小细胞肺癌患者肿瘤组织及血清中p16INK4A和CDH13的高甲基化
J Cell Physiol. 2006 Mar;206(3):611-5. doi: 10.1002/jcp.20503.
8
Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.肺癌转移过程中p16INK4基因因高甲基化而失活的频率增加及其与p53状态的关系。
Clin Cancer Res. 2000 Nov;6(11):4307-13.
9
Highly sensitive determination of the methylated p16 gene in cancer patients by microchip electrophoresis.通过微芯片电泳对癌症患者甲基化p16基因进行高灵敏度测定。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):145-51. doi: 10.1016/j.jchromb.2004.11.045.
10
Predicting lung cancer by detecting aberrant promoter methylation in sputum.通过检测痰液中异常的启动子甲基化来预测肺癌。
Cancer Res. 2000 Nov 1;60(21):5954-8.

引用本文的文献

1
DNA Methylation Markers in Lung Cancer.肺癌中的DNA甲基化标志物
Curr Genomics. 2021 Feb;22(2):79-87. doi: 10.2174/1389202921999201013164110.
2
MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.MPDZ作为一种新型的表观遗传沉默肿瘤抑制因子,通过Hippo-YAP信号通路抑制肺癌的生长和进展。
Oncogene. 2021 Jul;40(26):4468-4485. doi: 10.1038/s41388-021-01857-8. Epub 2021 Jun 9.
3
Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker.
用于乳腺癌的游离循环肿瘤DNA分析及其作为生物标志物的临床应用。
Oncotarget. 2017 Sep 1;8(43):75742-75755. doi: 10.18632/oncotarget.20608. eCollection 2017 Sep 26.
4
Upconversion Nanoparticle-Based Förster Resonance Energy Transfer for Detecting DNA Methylation.基于上转换纳米粒子的荧光共振能量转移用于检测DNA甲基化
Sensors (Basel). 2016 Aug 9;16(8):1259. doi: 10.3390/s16081259.
5
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.循环肿瘤细胞、外泌体和循环肿瘤核酸具有临床应用价值吗?分子病理学协会的一份报告。
J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001.
6
DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.使用具有改进降噪算法的压电板传感器进行灵敏度为100 zM的DNA杂交检测。
Analyst. 2014 Jun 7;139(11):2754-63. doi: 10.1039/c4an00215f.
7
Sputum-based molecular biomarkers for the early detection of lung cancer: limitations and promise.基于痰液的分子生物标志物用于肺癌的早期检测:局限性与前景。
Cancers (Basel). 2011 Jul 19;3(3):2975-89. doi: 10.3390/cancers3032975.
8
Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.游离循环 DNA 的定量和定性特征在非小细胞肺癌患者管理中的作用。
Cell Oncol (Dordr). 2013 Dec;36(6):439-48. doi: 10.1007/s13402-013-0155-3. Epub 2013 Nov 1.
9
LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.LHX6 作为一种新型潜在的抑癌基因,在肺癌中通过表观遗传失活发挥作用。
Cell Death Dis. 2013 Oct 24;4(10):e882. doi: 10.1038/cddis.2013.366.
10
The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.循环游离 DNA(CCFDNA)在癌症患者血液中的临床应用。
Int J Mol Sci. 2013 Sep 13;14(9):18925-58. doi: 10.3390/ijms140918925.